These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24884591)

  • 1. Changing cluster composition in cluster randomised controlled trials: design and analysis considerations.
    Corrigan N; Bankart MJ; Gray LJ; Smith KL
    Trials; 2014 May; 15():184. PubMed ID: 24884591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appropriate statistical methods for analysing partially nested randomised controlled trials with continuous outcomes: a simulation study.
    Candlish J; Teare MD; Dimairo M; Flight L; Mandefield L; Walters SJ
    BMC Med Res Methodol; 2018 Oct; 18(1):105. PubMed ID: 30314463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of varying cluster size in cross-sectional stepped-wedge cluster randomised trials.
    Martin JT; Hemming K; Girling A
    BMC Med Res Methodol; 2019 Jun; 19(1):123. PubMed ID: 31200640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimum number of clusters and comparison of analysis methods for cross sectional stepped wedge cluster randomised trials with binary outcomes: A simulation study.
    Barker D; D'Este C; Campbell MJ; McElduff P
    Trials; 2017 Mar; 18(1):119. PubMed ID: 28279222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An imbalance in cluster sizes does not lead to notable loss of power in cross-sectional, stepped-wedge cluster randomised trials with a continuous outcome.
    Kristunas CA; Smith KL; Gray LJ
    Trials; 2017 Mar; 18(1):109. PubMed ID: 28270224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allowing for imprecision of the intracluster correlation coefficient in the design of cluster randomized trials.
    Turner RM; Prevost AT; Thompson SG
    Stat Med; 2004 Apr; 23(8):1195-214. PubMed ID: 15083478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cluster randomised trials with different numbers of measurements at baseline and endline: Sample size and optimal allocation.
    Copas AJ; Hooper R
    Clin Trials; 2020 Feb; 17(1):69-76. PubMed ID: 31580144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample size calculation for a stepped wedge trial.
    Baio G; Copas A; Ambler G; Hargreaves J; Beard E; Omar RZ
    Trials; 2015 Aug; 16():354. PubMed ID: 26282553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracluster correlation coefficients and coefficients of variation for perinatal outcomes from five cluster-randomised controlled trials in low and middle-income countries: results and methodological implications.
    Pagel C; Prost A; Lewycka S; Das S; Colbourn T; Mahapatra R; Azad K; Costello A; Osrin D
    Trials; 2011 Jun; 12():151. PubMed ID: 21672223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Power and sample size calculations for cluster randomized trials with binary outcomes when intracluster correlation coefficients vary by treatment arm.
    Kennedy-Shaffer L; Hughes MD
    Clin Trials; 2022 Feb; 19(1):42-51. PubMed ID: 34879711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A note on sample size calculations for cluster randomised crossover trials with a fixed number of clusters.
    Kelly TL; Pratt N
    Stat Med; 2019 Aug; 38(18):3342-3345. PubMed ID: 31069820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A priori postulated and real power in cluster randomized trials: mind the gap.
    Guittet L; Giraudeau B; Ravaud P
    BMC Med Res Methodol; 2005 Aug; 5():25. PubMed ID: 16109162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mind the gap: covariate constrained randomisation can protect against substantial power loss in parallel cluster randomised trials.
    Kristunas C; Grayling M; Gray LJ; Hemming K
    BMC Med Res Methodol; 2022 Apr; 22(1):111. PubMed ID: 35413793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The optimal design of stepped wedge trials with equal allocation to sequences and a comparison to other trial designs.
    Thompson JA; Fielding K; Hargreaves J; Copas A
    Clin Trials; 2017 Dec; 14(6):639-647. PubMed ID: 28797179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysing cluster randomised controlled trials using GLMM, GEE1, GEE2, and QIF: results from four case studies.
    Offorha BC; Walters SJ; Jacques RM
    BMC Med Res Methodol; 2023 Dec; 23(1):293. PubMed ID: 38093221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracluster correlation adjustments to maintain power in cluster trials for binary outcomes.
    Chakraborty H; Moore J; Hartwell TD
    Contemp Clin Trials; 2009 Sep; 30(5):473-80. PubMed ID: 19386285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re-estimating sample size in cluster randomised trials with active recruitment within clusters.
    van Schie S; Moerbeek M
    Stat Med; 2014 Aug; 33(19):3253-68. PubMed ID: 24719285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accounting for expected attrition in the planning of cluster randomized trials for assessing treatment effect heterogeneity.
    Tong J; Li F; Harhay MO; Tong G
    BMC Med Res Methodol; 2023 Apr; 23(1):85. PubMed ID: 37024809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of methods for estimating the intraclass correlation coefficient for binary responses in cancer prevention cluster randomized trials.
    Wu S; Crespi CM; Wong WK
    Contemp Clin Trials; 2012 Sep; 33(5):869-80. PubMed ID: 22627076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.